A Louisiana Senate health committee yesterday passed a bill that will stop drug manufacturer interference with 340B contract pharmacy arrangements, rejecting an amendment that would have stripped the language from the measure.
HB 548, which also would prohibit pharmacy benefit manager and payor practices that lower reimbursement for 340B-purchased drugs, is now before the Senate floor for final action. The state House passed it 97-2 on April 26.
A Louisiana Senate health committee yesterday passed a bill that will stop drug manufacturer interference with 340B contract pharmacy arrangements, rejecting an amendment that would have stripped the language from the measure. HB 548, which also would prohibit pharmacy benefit […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
